Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt
May 30, 2024 07:30 ET | Evome Medical Technologies Inc.
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue...
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled
April 12, 2024 07:30 ET | Evome Medical Technologies Inc.
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the “Company” or “Evome”) highlighted the strengthening credit relationship with Pathward, N.A. (“Pathward”), the...
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt
April 02, 2024 11:18 ET | Evome Medical Technologies Inc.
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) has reached an agreement with EB Sports Corp. (the “Buyer”)‎, the parent company...
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
April 01, 2024 07:30 ET | Evome Medical Technologies Inc.
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) announced today preliminary annual financial results for the year ending December 31, 2023....
Evome Medical Engages ICP Securities Inc. for Automated Market Making Services
February 27, 2024 17:00 ET | Evome Medical Technologies Inc.
NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) --  Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT), is pleased to announce that it has engaged the services of ICP Securities...
Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman
February 15, 2024 07:30 ET | Evome Medical Technologies Inc.
NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) announces the appointment of two senior healthcare executives to its Board of Directors.‎ Mr....
Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024
February 08, 2024 07:30 ET | Evome Medical Technologies Inc.
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) has executed a non-binding letter of intent (LOI) to extend acquisition debt of US$3,294,440 to...
Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-Out
January 31, 2024 07:30 ET | Evome Medical Technologies Inc.
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the ‎‎‎“Company”) ‎‎‎(TSXV: EVMT) announced it has reduced acquisition bank debt by $535,093 as a result of the sale of...
Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors
January 18, 2024 07:30 ET | Salona Global Medical Device Corporation
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“Company”) ‎‎(TSXV:SGMD), is pleased to announce its corporate name change to Evome Medical Technologies...
Salona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution Company
January 11, 2024 07:30 ET | Salona Global Medical Device Corporation
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“Company”) ‎‎(TSXV:SGMD), announced today it has executed an exclusive distribution agreement with...